drugset / Trial / NCT00005081
Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive Glioma
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining carmustine and O6-benzylguanine in treating patients who have recurrent or progressive glioma.
Timeline
- Start
- 2000-08
- Primary completion
- 2001-04
- Completion
- 2001-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | O6-benzylguanine | Small molecule | — | Intravenous |
| Subject | carmustine | Small molecule | — | Intravenous |